Table 2.
Site | Event | Amplitude | Duration, s | Spread, μm2 | AUC | |
---|---|---|---|---|---|---|
Summary of Basal Ca2+ Activity | ||||||
WT | 51 ± 6 | 103 ± 19 | 1.26 ± 0.03 | 7.2 ± 1.2 | 13.5 ± 3.0 | |
SK3−/− | 101 ± 15* | 181 ± 24* | 1.36 ± 0.03 | 7.1 ± 0.9 | 16.9 ± 2.1 | |
Normalized Activity Change in Response to GSK, % | ||||||
WT | 138 ± 14 | 109 ± 14 | 100 ± 0.3 | 174 ± 14 | 121 ± 8 | 203 ± 32 |
SK3−/− | 169 ± 12 | 126 ± 18 | 101 ± 0.8 | 124 ± 14 | 106 ± 14 | 219 ± 78 |
Summary of Ca2+ dynamic analysis using LC_Pro obtained from WT and SK3−/− endothelium. Ca2+ dynamics were analyzed using the automated Ca2+ detection program LC_Pro, including number of Ca2+ sites, total number of events, amplitudes (F/FO), duration, and spread of Ca2+ signal. WT: n = 14; SK3−/−: n = 9.
P < 0.05 comparing WT and SK3−/− using t-tests. A summary of each of these Ca2+ parameters in the presence of GSK is normalized to that prior to the application of GSK. n = 6 each. AUC, area under curve.